| Dr Ali Akber Turabi, MD | |
|
9040 Jackson Ave Madigan Army Medical Center, Tacoma, WA 98431-0001 | |
| (253) 968-2543 | |
| Not Available |
| Full Name | Dr Ali Akber Turabi |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 17 Years |
| Location | 9040 Jackson Ave Madigan Army Medical Center, Tacoma, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013108232 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 60811752 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Union Memorial Hospital | Baltimore, MD | Hospital |
| Medstar Harbor Hospital | Baltimore, MD | Hospital |
| Medstar Good Samaritan Hospital | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
News Archive
The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.
Pediatric researchers have discovered a new biological pathway in which small segments of RNA, called microRNA, help protect red blood cells from injury caused by chemicals called free radicals. The microRNA seems to have only a modest role when red blood cells experience normal conditions, but steps into action when the cells are threatened by oxidant stress.
A Massachusetts General Hospital study has identified a new role for an important enzyme in preparing lung tissue for the development of metastases.
North Carolina's Senate race is being closely watched because the incumbent, Democrat Kay Hagan, is considered one of the most vulnerable this campaign season because of her support of the health law.
› Verified 1 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171207001966 |
News Archive
The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.
Pediatric researchers have discovered a new biological pathway in which small segments of RNA, called microRNA, help protect red blood cells from injury caused by chemicals called free radicals. The microRNA seems to have only a modest role when red blood cells experience normal conditions, but steps into action when the cells are threatened by oxidant stress.
A Massachusetts General Hospital study has identified a new role for an important enzyme in preparing lung tissue for the development of metastases.
North Carolina's Senate race is being closely watched because the incumbent, Democrat Kay Hagan, is considered one of the most vulnerable this campaign season because of her support of the health law.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ali Akber Turabi, MD 9040 Jackson Ave Madigan Army Medical Center, Tacoma, WA 98431-0001 Ph: (253) 968-2543 | Dr Ali Akber Turabi, MD 9040 Jackson Ave Madigan Army Medical Center, Tacoma, WA 98431-0001 Ph: (253) 968-2543 |
News Archive
The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.
Pediatric researchers have discovered a new biological pathway in which small segments of RNA, called microRNA, help protect red blood cells from injury caused by chemicals called free radicals. The microRNA seems to have only a modest role when red blood cells experience normal conditions, but steps into action when the cells are threatened by oxidant stress.
A Massachusetts General Hospital study has identified a new role for an important enzyme in preparing lung tissue for the development of metastases.
North Carolina's Senate race is being closely watched because the incumbent, Democrat Kay Hagan, is considered one of the most vulnerable this campaign season because of her support of the health law.
› Verified 1 days ago
Mr. Andrew J Irizarry, DNP, CRNA Anesthesiology Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 330-509-3934 | |
Glaucia De Castro Moreira, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1717 S J St, Tacoma, WA 98405 Phone: 253-426-6625 | |
Jonathan P Kryman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3300 | |
Dr. Douglas Hartnett, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3633 Pacific Ave, Suite 204, Tacoma, WA 98418 Phone: 253-274-1668 | |
Dr. Heather Leanne Higgins, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-3885 | |
Dr. Adam David Demars, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1102 A St Unit 1536, Tacoma, WA 98401 Phone: 206-669-8706 |